RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Leveraged Buyouts

A collection of news and information related to Leveraged Buyouts published by this site and its partners.

Top Leveraged Buyouts Articles

Displaying items 12-22
  • AT&T to acquire Leap Wireless in $1.2-billion deal

    AT&T to acquire Leap Wireless in $1.2-billion deal
    Seeking a foothold in the competitive prepaid wireless market, AT&T Inc. has agreed to acquire Leap Wireless International Inc. in a deal valued at about $1.2 billion. AT&T, the nation's second-largest wireless carrier, had been rumored to be in talks...
  • T. Rowe Price continues to oppose Dell buyout offer

    T. Rowe Price continues to oppose Dell buyout offer
    With a shareholder vote just days away, T. Rowe Price, one of Dell Inc.'s major investors, reaffirmed its opposition to a $24.4 billion buyout offer for the personal computer manufacturer. "We continue to believe the proposed buyout does not reflect the...
  • The week ahead for December 9-15: Hilton IPO; quarterly industrial data; IP changes [Pictures]

    The week ahead for December 9-15: Hilton IPO; quarterly industrial data; IP changes [Pictures]
    (Reuters) - Hilton Worldwide Inc said its initial public offering would raise up to $2.37 billion in the biggest-ever hotel IPO, more than doubling Blackstone Group LP's investment. According to reports last week, Hilton is expected to launch its...
  • Ackman, Valeant partner in bid to buy Botox maker Allergan

     Ackman, Valeant partner in bid to buy Botox maker Allergan
    Activist investor Bill Ackman is partnering with a Canadian pharmaceutical company in an effort to buy Allergan Inc., the Irvine company that makes the popular wrinkle treatment Botox. Ackman and Valeant Pharmaceuticals International Inc. have already...
  • Ackman and Valeant make bid for Allergan

    Ackman and Valeant make bid for Allergan
    Activist investor Bill Ackman and his unlikely Canadian partner, Valeant Pharmaceuticals International Inc., unveiled details of their bid for Irvine pharmaceutical company Allergan Inc., which makes the popular Botox wrinkle treatment. Valeant will...
  • Allergan adopts 'poison pill' defense in Valeant takeover bid

    Takeover target Allergan Inc., the company that makes Botox, has adopted a "poison pill" defense intended to delay a buyout by Canadian company Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman. The Irvine company's...
  • Jos. Bank to be acquired by Men's Wearhouse for $1.8 billion

    Jos. Bank to be acquired by Men's Wearhouse for $1.8 billion
    Jos. A. Bank Clothiers finally liked the look of Men's Wearhouse's takeover offer as the Hampstead-based retailer accepted a $1.8 billion buyout Tuesday. The deal would pay Bank's stockholders $65 a share cash, $10 more than Men's Wearhouse initially...
  • Allergan co-founder speaks out against Valeant takeover

    The board and chief executive of Irvine takeover target Allergan Inc. heard a voice from the past Tuesday at the company's annual meeting of shareholders. Gavin S. Herbert, Allergan's co-founder and former chairman, urged the company's directors to...
  • Botox-maker Allergan rejects takeover bid from Valeant

    Botox-maker Allergan Inc. said it rejected a takeover bid from Valeant Pharmaceuticals International Inc., a deal the company said undervalued its worth and posed significant risks to shareholders. Last month, the Irvine drugmaker received an...
  • A closer look at Mitt Romney's job creation record

    A closer look at Mitt Romney's job creation record
      Shortly after Mitt Romney resigned from Bain Capital in 1999 to run the Olympics in Salt Lake City, potential investors received a prospectus touting the extraordinary profits earned by the private equity firm that Romney controlled for 15 years....
  • Exelon boss wants merger badly, and he's paying for it

    John Rowe made no secret of the fact that he badly wanted a signature merger to top off his career as the chief executive of Exelon Corp. How badly can be seen in the settlement he just agreed to in Exelon's bid to purchase Baltimore's Constellation...